Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 766

1.

Biomimetic implant restoration made of human enamel and CAD/CAM block: a short report.

Mandelli F, Ghensi P, Traini T.

Quintessence Int. 2019;50(4):330-333. doi: 10.3290/j.qi.a42159.

PMID:
30887966
2.

The ability of marginal detection using different intraoral scanning systems: A pilot randomized controlled trial.

Ferrari M, Keeling A, Mandelli F, Lo Giudice G, Garcia-Godoy F, Joda T.

Am J Dent. 2018 Oct;31(5):272-276.

PMID:
30346675
3.

A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.

Efficace F, Boccadoro M, Palumbo A, Petrucci MT, Cottone F, Cannella L, Zamagni E, Niscola P, Kyriakou C, Caravita T, Offidani M, Mandelli F, Cavo M.

Health Qual Life Outcomes. 2018 Jun 18;16(1):127. doi: 10.1186/s12955-018-0953-4.

4.

Medial acetabular wall breach in total hip arthroplasty - is full-weight-bearing possible?

Mandelli F, Tiziani S, Schmitt J, Werner CML, Simmen HP, Osterhoff G.

Orthop Traumatol Surg Res. 2018 Sep;104(5):675-679. doi: 10.1016/j.otsr.2018.04.020. Epub 2018 Jun 13.

PMID:
29908355
5.

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes.

Efficace F, Cottone F, Abel G, Niscola P, Gaidano G, Bonnetain F, Anota A, Caocci G, Cronin A, Fianchi L, Breccia M, Stauder R, Platzbecker U, Palumbo GA, Luppi M, Invernizzi R, Bergamaschi M, Borin L, Di Tucci AA, Zhang H, Sprangers M, Vignetti M, Mandelli F.

Cancer. 2018 Mar 15;124(6):1251-1259. doi: 10.1002/cncr.31193. Epub 2017 Dec 12.

6.

The Biological Properties of OGI Surfaces Positively Act on Osteogenic and Angiogenic Commitment of Mesenchymal Stem Cells.

Ghensi P, Bressan E, Gardin C, Ferroni L, Soldini MC, Mandelli F, Soldini C, Zavan B.

Materials (Basel). 2017 Nov 17;10(11). pii: E1321. doi: 10.3390/ma10111321.

7.

Alveolar socket preservation with demineralised bovine bone mineral and a collagen matrix.

Maiorana C, Poli PP, Deflorian M, Testori T, Mandelli F, Nagursky H, Vinci R.

J Periodontal Implant Sci. 2017 Aug;47(4):194-210. doi: 10.5051/jpis.2017.47.4.194. Epub 2017 Aug 11.

8.

Improvement of a Digital Impression with Conventional Materials: Overcoming Intraoral Scanner Limitations.

Mandelli F, Ferrini F, Gastaldi G, Gherlone E, Ferrari M.

Int J Prosthodont. 2017 Jul/Aug;30(4):373-376. doi: 10.11607/ijp.5138.

PMID:
28697209
9.

Thermal adaptation strategies of the extremophile bacterium Thermus filiformis based on multi-omics analysis.

Mandelli F, Couger MB, Paixão DAA, Machado CB, Carnielli CM, Aricetti JA, Polikarpov I, Prade R, Caldana C, Paes Leme AF, Mercadante AZ, Riaño-Pachón DM, Squina FM.

Extremophiles. 2017 Jul;21(4):775-788. doi: 10.1007/s00792-017-0942-2. Epub 2017 May 12.

PMID:
28500387
10.

Biochemical and biophysical properties of a metagenome-derived GH5 endoglucanase displaying an unconventional domain architecture.

Pimentel AC, Ematsu GCG, Liberato MV, Paixão DAA, Franco Cairo JPL, Mandelli F, Tramontina R, Gandin CA, de Oliveira Neto M, Squina FM, Alvarez TM.

Int J Biol Macromol. 2017 Jun;99:384-393. doi: 10.1016/j.ijbiomac.2017.02.075. Epub 2017 Feb 24.

PMID:
28238914
11.

The Coptotermes gestroi aldo-keto reductase: a multipurpose enzyme for biorefinery applications.

Tramontina R, Franco Cairo JP, Liberato MV, Mandelli F, Sousa A, Santos S, Rabelo SC, Campos B, Ienczak J, Ruller R, Damásio AR, Squina FM.

Biotechnol Biofuels. 2017 Jan 3;10:4. doi: 10.1186/s13068-016-0688-6. eCollection 2017.

12.

Characterization and Low-Resolution Structure of an Extremely Thermostable Esterase of Potential Biotechnological Interest from Pyrococcus furiosus.

Mandelli F, Gonçalves TA, Gandin CA, Oliveira AC, Oliveira Neto M, Squina FM.

Mol Biotechnol. 2016 Nov;58(11):757-766.

PMID:
27665110
13.

Evaluation of the accuracy of extraoral laboratory scanners with a single-tooth abutment model: A 3D analysis.

Mandelli F, Gherlone E, Gastaldi G, Ferrari M.

J Prosthodont Res. 2017 Oct;61(4):363-370. doi: 10.1016/j.jpor.2016.09.002. Epub 2016 Oct 19.

PMID:
27771189
14.

A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.

Chiaretti S, Vitale A, Vignetti M, Piciocchi A, Fazi P, Elia L, Falini B, Ronco F, Ferrara F, De Fabritiis P, Luppi M, La Nasa G, Tedeschi A, Califano C, Fanin R, Dore F, Mandelli F, Meloni G, Foà R.

Haematologica. 2016 Dec;101(12):1544-1552. Epub 2016 Aug 11.

15.

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F.

J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.

16.

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.

Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F, Borchiellini A, Carpenedo M, Simula MP, Di Giacomo V, Bergamaschi M, Vincelli ID, Rodeghiero F, Ruggeri M, Scaramucci L, Rambaldi A, Cascavilla N, Forghieri F, Petrungaro A, Ditonno P, Caocci G, Cirrincione S, Mazzucconi MG.

Am J Hematol. 2016 Oct;91(10):995-1001. doi: 10.1002/ajh.24463. Epub 2016 Jul 14.

17.

PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.

Cicconi L, Divona M, Ciardi C, Ottone T, Ferrantini A, Lavorgna S, Alfonso V, Paoloni F, Piciocchi A, Avvisati G, Ferrara F, Di Bona E, Albano F, Breccia M, Cerqui E, Sborgia M, Kropp MG, Santoro A, Levis A, Sica S, Amadori S, Voso MT, Mandelli F, Lo-Coco F.

Leukemia. 2016 Oct;30(10):1987-1992. doi: 10.1038/leu.2016.122. Epub 2016 May 2.

PMID:
27133819
18.

Improving accuracy of prognosis in patients with myelodysplastic syndromes using self-reported quality of life data. Opportunities for a new research agenda in developing prognostic models.

Niscola P, Mandelli F, Efficace F.

Expert Rev Hematol. 2016 May;9(5):415-7. doi: 10.1586/17474086.2016.1164030. Epub 2016 Mar 24. No abstract available.

PMID:
26954305
19.

The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia.

Efficace F, Rosti G, Breccia M, Cottone F, Giesinger JM, Stagno F, Iurlo A, Russo Rossi A, Luciano L, Martino B, Galimberti S, Turri D, Bergamaschi M, Tiribelli M, Fava C, Angelucci E, Mandelli F, Baccarani M.

Ann Hematol. 2016 Jan;95(2):211-9. doi: 10.1007/s00277-015-2541-6. Epub 2015 Nov 7.

PMID:
26546359
20.

Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia.

Efficace F, Mandelli F, Platzbecker U, Cottone F, Lo Coco F.

Blood. 2015 Nov 26;126(22):2523-4. doi: 10.1182/blood-2015-07-658922. Epub 2015 Oct 9. No abstract available.

21.

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study.

Efficace F, Gaidano G, Breccia M, Voso MT, Cottone F, Angelucci E, Caocci G, Stauder R, Selleslag D, Sprangers M, Platzbecker U, Ricco A, Sanpaolo G, Beyne-Rauzy O, Buccisano F, Palumbo GA, Bowen D, Nguyen K, Niscola P, Vignetti M, Mandelli F.

Lancet Oncol. 2015 Nov;16(15):1506-1514. doi: 10.1016/S1470-2045(15)00206-5. Epub 2015 Sep 21.

PMID:
26404501
22.

Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?

Cannella L, Caocci G, Jacobs M, Vignetti M, Mandelli F, Efficace F.

Crit Rev Oncol Hematol. 2015 Dec;96(3):542-54. doi: 10.1016/j.critrevonc.2015.07.012. Epub 2015 Aug 1. Review.

PMID:
26324461
23.

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

Caocci G, Voso MT, Angelucci E, Stauder R, Cottone F, Abel G, Nguyen K, Platzbecker U, Beyne-Rauzy O, Gaidano G, Invernizzi R, Molica S, Criscuolo M, Breccia M, Lübbert M, Sanpaolo G, Buccisano F, Ricco A, Palumbo GA, Niscola P, Zhang H, Fenu S, La Nasa G, Mandelli F, Efficace F.

Leuk Res. 2015 Aug;39(8):859-65. doi: 10.1016/j.leukres.2015.05.012. Epub 2015 Jun 12.

PMID:
26120100
24.

Draft Genome Sequence of the Thermophile Thermus filiformis ATCC 43280, Producer of Carotenoid-(Di)glucoside-Branched Fatty Acid (Di)esters and Source of Hyperthermostable Enzymes of Biotechnological Interest.

Mandelli F, Oliveira Ramires B, Couger MB, Paixão DA, Camilo CM, Polikarpov I, Prade R, Riaño-Pachón DM, Squina FM.

Genome Announc. 2015 May 14;3(3). pii: e00475-15. doi: 10.1128/genomeA.00475-15.

25.

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.

Hengeveld M, Suciu S, Chelgoum Y, Marie JP, Muus P, Lefrère F, Mandelli F, Pane F, Amadori S, Fioritoni G, Labar B, Baron F, Cermak J, Bourhis JH, Storti G, Fazi P, Hagemeijer A, Vignetti M, Willemze R, de Witte T.

Bone Marrow Transplant. 2015 Mar;50(3):341-7. doi: 10.1038/bmt.2014.262. Epub 2014 Nov 17.

26.

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.

Efficace F, Gaidano G, Breccia M, Criscuolo M, Cottone F, Caocci G, Bowen D, Lübbert M, Angelucci E, Stauder R, Selleslag D, Platzbecker U, Sanpaolo G, Jonasova A, Buccisano F, Specchia G, Palumbo GA, Niscola P, Wan C, Zhang H, Fenu S, Klimek V, Beyne-Rauzy O, Nguyen K, Mandelli F.

Br J Haematol. 2015 Feb;168(3):361-70. doi: 10.1111/bjh.13138. Epub 2014 Oct 1.

PMID:
25272332
27.

Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes.

Efficace F, Mandelli F, Avvisati G, Cottone F, Ferrara F, Di Bona E, Specchia G, Breccia M, Levis A, Sica S, Finizio O, Kropp MG, Fioritoni G, Cerqui E, Vignetti M, Amadori S, Schlenk RF, Platzbecker U, Lo-Coco F.

J Clin Oncol. 2014 Oct 20;32(30):3406-12. doi: 10.1200/JCO.2014.55.3453. Epub 2014 Sep 22.

PMID:
25245446
28.

Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.

Efficace F, Santini V, La Nasa G, Cottone F, Finelli C, Borin L, Quaresmini G, Di Tucci AA, Volpe A, Cilloni D, Quarta G, Sanpaolo G, Rivellini F, Salvi F, Molteni A, Voso MT, Alimena G, Fenu S, Mandelli F, Angelucci E.

BMJ Support Palliat Care. 2016 Mar;6(1):80-8. doi: 10.1136/bmjspcare-2014-000726. Epub 2014 Sep 9.

PMID:
25204541
29.

Implantology and otorhinolaryngology team-up to solve a complicated case.

Felisati G, Saibene AM, Pipolo C, Mandelli F, Testori T.

Implant Dent. 2014 Oct;23(5):617-21. doi: 10.1097/ID.0000000000000146.

PMID:
25192161
30.

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.

Oosterveld M, Suciu S, Muus P, Germing U, Delforge M, Belhabri A, Aul C, Selleslag D, Ferrant A, Marie JP, Amadori S, Jehn U, Mandelli F, Hess U, Hellström-Lindberg E, Cakmak-Wollgast S, Vignetti M, Labar B, Willemze R, de Witte T.

Ann Hematol. 2015 Jan;94(1):23-34. doi: 10.1007/s00277-014-2177-y. Epub 2014 Aug 7.

PMID:
25096636
31.

Development of hemicellulolytic enzyme mixtures for plant biomass deconstruction on target biotechnological applications.

Goldbeck R, Damásio AR, Gonçalves TA, Machado CB, Paixão DA, Wolf LD, Mandelli F, Rocha GJ, Ruller R, Squina FM.

Appl Microbiol Biotechnol. 2014 Oct;98(20):8513-25. doi: 10.1007/s00253-014-5946-6. Epub 2014 Jul 31.

PMID:
25077777
32.

A 3 years retrospective study of survival for zirconia-based single crowns fabricated from intraoral digital impressions.

Gherlone E, Mandelli F, Capparè P, Pantaleo G, Traini T, Ferrini F.

J Dent. 2014 Sep;42(9):1151-5. doi: 10.1016/j.jdent.2014.06.002. Epub 2014 Jun 12.

PMID:
24930869
33.

A novel technique to prevent the loss of graft material through the antrostomy after sinus surgery: technical note.

Testori T, Mandelli F, Valentini P, Wallace S.

Int J Oral Maxillofac Implants. 2014 May-Jun;29(3):e272-4. doi: 10.11607/jomi.3367.

PMID:
24818216
34.

Early and late complications related to central venous catheters in hematological malignancies: a retrospective analysis of 1102 patients.

Morano SG, Coppola L, Latagliata R, Berneschi P, Chistolini A, Micozzi A, Girmenia C, Breccia M, Brunetti G, Massaro F, Rosa G, Guerrisi P, Mandelli F, Foà R, Alimena G.

Mediterr J Hematol Infect Dis. 2014 Feb 14;6(1):e2014011. doi: 10.4084/MJHID.2014.011. eCollection 2014.

35.
36.

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, Di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F.

Ann Oncol. 2014 Feb;25(2):447-54. doi: 10.1093/annonc/mdt557.

PMID:
24478321
37.

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

Willemze R, Suciu S, Meloni G, Labar B, Marie JP, Halkes CJ, Muus P, Mistrik M, Amadori S, Specchia G, Fabbiano F, Nobile F, Sborgia M, Camera A, Selleslag DL, Lefrère F Sr, Magro D, Sica S, Cantore N, Beksac M, Berneman Z, Thomas X, Melillo L, Guimaraes JE, Leoni P, Luppi M, Mitra ME, Bron D, Fillet G, Marijt EW, Venditti A, Hagemeijer A, Mancini M, Jansen J, Cilloni D, Meert L, Fazi P, Vignetti M, Trisolini SM, Mandelli F, de Witte T.

J Clin Oncol. 2014 Jan 20;32(3):219-28. doi: 10.1200/JCO.2013.51.8571. Epub 2013 Dec 2.

38.

Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.

Efficace F, Rosti G, Aaronson N, Cottone F, Angelucci E, Molica S, Vignetti M, Mandelli F, Baccarani M.

Haematologica. 2014 Apr;99(4):788-93. doi: 10.3324/haematol.2013.093724. Epub 2013 Nov 15.

39.

Sinus floor elevation with crestal approach and immediately loaded post-extraction implants.

Mandelli F, Ghensi P, Vinci R, Mandelli G.

J Indiana Dent Assoc. 2013 Winter;92(1):22-4; quiz 25.

PMID:
24159683
40.

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.

Malagola M, Breccia M, Skert C, Cancelli V, Soverini S, Iacobucci I, Cattina F, Liberati AM, Tiribelli M, Annunziata M, Trabacchi E, De Vivo A, Castagnetti F, Martinelli G, Fogli M, Stagno F, Pica G, Iurlo A, Pregno P, Abruzzese E, Pardini S, Bocchia M, Russo S, Pierri I, Lunghi M, Barulli S, Merante S, Mandelli F, Alimena G, Rosti G, Baccarani M, Russo D.

Am J Hematol. 2014 Feb;89(2):119-24. doi: 10.1002/ajh.23593.

41.

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F.

Qual Life Res. 2014 Apr;23(3):825-36. doi: 10.1007/s11136-013-0523-5. Epub 2013 Sep 13.

PMID:
24026634
42.

Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors.

Efficace F, Rosti G, Cottone F, Breccia M, Castagnetti F, Iurlo A, Mandelli F, Baccarani M.

Leuk Res. 2014 Mar;38(3):294-8. doi: 10.1016/j.leukres.2013.07.003. Epub 2013 Jul 30.

PMID:
23906625
43.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lübbert M, Hänel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Döhner K, Sauer M, Ganser A, Amadori S, Mandelli F, Döhner H, Ehninger G, Schlenk RF, Platzbecker U; Gruppo Italiano Malattie Ematologiche dell'Adulto; German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia.

N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.

44.

Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.

Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P, Valsecchi MG, Elia L, Testi AM, Mancini F, Conter V, te Kronnie G, Ferrara F, Di Raimondo F, Tedeschi A, Fioritoni G, Fabbiano F, Meloni G, Specchia G, Pizzolo G, Mandelli F, Guarini A, Basso G, Biondi A, Foà R.

Haematologica. 2013 Nov;98(11):1702-10. doi: 10.3324/haematol.2012.080432. Epub 2013 May 28.

45.

Accidental falls in home care hematological patients.

Tendas A, Cupelli L, Trawinska MM, Lentini L, Giovannini M, Scaramucci L, Palombi M, Brunetti GA, Cartoni C, de Fabritiis P, Niscola P, Mandelli F.

Support Care Cancer. 2013 Aug;21(8):2087-9. doi: 10.1007/s00520-013-1828-1. Epub 2013 May 3. No abstract available.

PMID:
23640299
46.

Tilted trans-sinus implants for the treatment of maxillary atrophy: case series of 35 consecutive patients.

Testori T, Mandelli F, Mantovani M, Taschieri S, Weinstein RL, Del Fabbro M.

J Oral Maxillofac Surg. 2013 Jul;71(7):1187-94. doi: 10.1016/j.joms.2013.02.013. Epub 2013 Apr 21.

PMID:
23611604
47.

The characterization of a thermostable and cambialistic superoxide dismutase from Thermus filiformis.

Mandelli F, Franco Cairo JP, Citadini AP, Büchli F, Alvarez TM, Oliveira RJ, Leite VB, Paes Leme AF, Mercadante AZ, Squina FM.

Lett Appl Microbiol. 2013 Jul;57(1):40-6. doi: 10.1111/lam.12071. Epub 2013 Apr 12.

48.

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib.

Efficace F, Baccarani M, Breccia M, Cottone F, Alimena G, Deliliers GL, Baratè C, Specchia G, Di Lorenzo R, Luciano L, Turri D, Martino B, Stagno F, Dabusti M, Bergamaschi M, Leoni P, Simula MP, Levato L, Fava C, Veneri D, Sica S, Rambaldi A, Rosti G, Vignetti M, Mandelli F.

Leukemia. 2013 Jul;27(7):1511-9. doi: 10.1038/leu.2013.51. Epub 2013 Feb 18.

PMID:
23417029
49.

Biomass-to-bio-products application of feruloyl esterase from Aspergillus clavatus.

Damásio AR, Braga CM, Brenelli LB, Citadini AP, Mandelli F, Cota J, de Almeida RF, Salvador VH, Paixao DA, Segato F, Mercadante AZ, de Oliveira Neto M, do Santos WD, Squina FM.

Appl Microbiol Biotechnol. 2013 Aug;97(15):6759-67. doi: 10.1007/s00253-012-4548-4. Epub 2012 Nov 16.

PMID:
23229566
50.

Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review.

Efficace F, Cardoni A, Cottone F, Vignetti M, Mandelli F.

Leuk Res. 2013 Feb;37(2):206-13. doi: 10.1016/j.leukres.2012.10.021. Epub 2012 Nov 22. Review.

PMID:
23177797

Supplemental Content

Loading ...
Support Center